Geneva Pharma Network

Calypso Biotech SA

Rate this item
(0 votes)

Calypso Biotech SA is a preclinical stage company discovering and developing antibody therapies for severe gastrointestinal diseases. Calypso Biotech SA is a spin-off from Merck-Serono incorporated in 2013 with offices and laboratory within the Eclosion incubator in Plan-les-Ouates and currently has 3 employees.

Additional Info

  • Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Contact at GPN: Alain Vicari